2013
DOI: 10.1007/s12558-013-0296-3
|View full text |Cite
|
Sign up to set email alerts
|

Cancers urologiques au Togo : profil histoépidémiologique à propos de 678 cas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
9
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 8 publications
2
9
0
Order By: Relevance
“…In Africa in general and Burkina Faso in particular, data on urological cancers are scarce due to the unavailability of effective collection tools, notably a operational cancer registry [3]. In recent years, we have seen an increase in the frequency of urological cancers in the various urology divisions in Burkina Faso [4].…”
Section: Introductionmentioning
confidence: 99%
“…In Africa in general and Burkina Faso in particular, data on urological cancers are scarce due to the unavailability of effective collection tools, notably a operational cancer registry [3]. In recent years, we have seen an increase in the frequency of urological cancers in the various urology divisions in Burkina Faso [4].…”
Section: Introductionmentioning
confidence: 99%
“…The author reported 14.7% of urological tumors [5]. These tumors were also dominated by prostate cancer, followed by bladder cancer.…”
Section: Etiological Aspectsmentioning
confidence: 98%
“…Benatta et al in Algeria [11], Rachida et al in Algeria [17], Troh [18] et al in Ivory Coast, Mugisho [19] Luhiriri et al in DRC[20] found respectively that 49.2% of biop-According to the Gleason score for prostate adenocarcinomas found in our study, 41.7% of tumors were moderately differentiated (Gleason 7). Benatta et al in Algeria[11], Tengue et al[12], Darre et al[21] in Togo found respectively 59.7%, 34.5% and 29.58% of moderately differentiated tumors. On the other hand, Hounasso et al in Benin [22], Dehayni et al in Morocco…”
mentioning
confidence: 94%